Average Co-Inventor Count = 6.15
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (11 from 2,405 patents)
2. Merck + Co., Inc. (10 from 4,770 patents)
3. Other (2 from 832,680 patents)
4. Sirna Therapeutics, Inc. (2 from 138 patents)
25 patents:
1. 10208064 - Inhibitors of the renal outer medullary potassium channel
2. 10131674 - Process for preparing Substituted Indole Compounds
3. 9926317 - Inhibitors of the renal outer medullary potassium channel
4. 9765107 - Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
5. 9732111 - 2'-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
6. 9512426 - Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
7. 9457039 - 2'-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
8. 9242988 - 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
9. 9156872 - 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
10. 9150603 - 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
11. 9061041 - 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
12. 8877439 - Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
13. 7718796 - Process for the preparation of caprolactam CGRP antagonist
14. 6800647 - 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis
15. 6673935 - 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis